Blood test could help doctors Fine-Tune arthritis treatment
NCT ID NCT01382160
Summary
This study aimed to find out if measuring the amount of adalimumab (Humira) in a patient's blood can predict how well the drug will control their rheumatoid arthritis. Researchers followed 69 patients for 6 months, checking drug levels and disease activity markers. The goal was to gather information that might help doctors adjust doses sooner to get the best results for each patient.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for RHEUMATOID ARTHRITIS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
CHR d'Orléans
Orléans, France
-
CHR du Mans
Le Mans, France
-
CHRU de Brest
Brest, France
-
CHRU de Nantes
Nantes, France
-
CHRU de Poitiers
Poitiers, France
-
CHRU de Rennes
Rennes, France
-
CHRU de Tours
Tours, France
Conditions
Explore the condition pages connected to this study.